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Abstract: For successful fertilization, a transfer system named “rapid sperm transport” generated by uterine contractions plays a crucial
role. The purpose of this in vivo study was to investigate the effect of buserelin, a GnRH agonist widely used for ovulation induction
after mating or artificial insemination, on bovine uterine contractility which supports rapid sperm transport at estrus. In vivo uterine
contractile activity was measured by intrauterine pressure recording technique. In the study, the spontaneous uterine contractile
activities of 28 cows at estrus were observed for 30 min. The cows were randomly divided into 4 treatment groups which have 7 cows
each of and were injected appropriate agents as follows; two different clinical doses of buserelin (10.5 µg, 21 µg), oxytocin (50 IU) and
control (placebo). Following treatment, drug-induced uterine activity was measured for 60 min. There were no differences in terms of
frequency in all groups observed. Oxytocin which is known as an effective uterotonic increased the amplitude and area under curve of
contraction at estrus. Two different doses of buserelin were observed to have no effect on uterine contractile activity in cows throughout
60 min. It was concluded that GnRH has no function on bovine uterine contractility which plays a role in sperm transportation at estrus.
Key words: Buserelin, GnRH, uterine contractility, estrus, cow

1. Introduction
Uterine contractility plays crucial roles for rapid sperm
transport, a passive transfer system which supports the
spermatozoon movements in the female genital tract [1].
In follicular phase, the contractile activity of bovine uterus
has been reported to be higher compared to the luteal phase
because of varying steroid hormones profile and their
receptor expression [2,3]. Peak levels of uterine contractile
activity are observed, particularly in the second half of
estrus, then it weakens again with the ovulation. It is also
reported that the propagating waves of contractions move
towards the uterine tubes in the second half of the estrus
in a regular manner [4]. This contraction pattern plays
an important role in the rapid transport of spermatozoa
during the second half of the estrus when the cows are
subjected to mating or artificial insemination [4, 5].
Hormonal modulation of uterine contractility is proven
by steroid hormones, oxytocin and B2 adrenergic agonists
and their receptor expression [6]. There are several in
vitro and in vivo studies investigating the dose-dependent,
species-specific and in different sexual phase effect of
various reproductive hormones including estradiol [3],
progestogens [7,8], chorionic gonadotrophin [9,10],
prostaglandins [11,12] and oxytocin [13,14] on uterine
contractile activity. However, there is limited information

about the effects of GnRH and synthetic GnRH agonists
on uterine contractility. In vitro studies [15,16] showed
that GnRH can modulate the uterine contractile activity.
It was shown that while dose-dependent and cycle phase
related stimulation was occurred in bovine uterine strips
[15,16], increasing doses of GnRH caused direct inhibition
in rat uterine stripsin dose and time dependent manner
[17]. Giammarino et al. [15] also reported that GnRH was
more effective in uterine strips in follicular phase than in
luteal phase because of more biologically active GnRH
receptors. Additionally, this study highlighted that when
GnRH receptors were invaded by GnRH antagonists,
the increased doses of GnRH did not have an impact on
uterine contractility in strips both follicular and luteal
phase.
Endogenous GnRH, a decapeptide produced from
hypothalamus, is secreted to hypophyseal portal circulation
in a pulsatile manner, thus it is known that GnRH could
not join the peripheral circulation [18]. However, in
recent years, GnRH may have different functions in some
reproductive tissues and organs besides the pituitary, and
the presence of GnRH receptor has been observed in
several reproductive tissues in various species [19–22].
Moreover, the presence of GnRH receptors in bovine
uterus and oviduct have been proved for the first time
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and revealed that there has been no difference in GnRH
receptors’ expression pattern compared to the receptors in
the pituitary [20].
However, there is no clear information about the
function of synthetic GnRH agonists with GnRH
receptors in these nonpituitary regions. Buserelin
administration was estimated to affect the increase in
uterine contractility by increasing the intracellular level of
Ca++ through a series of intracellular pathways similar to
oxytocin, which supports the direct effect on the paired
receptor using agonistic (buserelin) heptahelical G protein
(pharmaco-mechanical coupling) [23]. Although in vitro
studies [15,16] have shown an inductive effect on uterine
contractility, especially in the follicular phase, the in vivo
effect of supraphysiological doses of GnRH is unknown.
We hypothesize that administration of clinical doses of
synthetic GnRH agonist at estrus stimulate the bovine
uterine activity which supports rapid sperm transport. For
this reason, we aimed to investigate the clinical efficacy of
buserelin on in vivo bovine uterine contractile activity at
estrus.
2. Materials and methods
2.1. Animals
This study was carried out in Agriculture and Livestock
Research Farm. The permission of the Animal Experiments
Local Ethics Committee was received before the study
(2014/8 - 85). Cows used in this study were fed with same
total mixed ration and had ad libitum access to water in a
free-range barn. Cows had body condition scores ranging
3.25 to 3.75. Milking was performed twice a day. Average
milk yield was approximately 2l.0 L. In the study, 28 Brown
Swiss cows, in pp Day 70–120, aging between 3–8 and that
were not pregnant and completed the voluntary waiting
period (until pp Day 60) without problems, were used as
subjects.
Experimental protocol was applied at the second half
of the spontaneous estrus which were determined as
6–8 h after the first observation of external estrus signs.
However, before this spontaneous estrus, to eliminate
possible luteolysis delay or luteal phase elongation, an
estrous cycle, called control cycle, was monitored without
any intervention. Reproductive records of cows were
examined, their transrectal ultrasonographic examinations
were carried out and the stage of their sexual cycle was
determined. Follow-up of the estrus signs in cows was
performed with careful observation of the external signs of
the estrus and lasted 30 min 3 times a day. Cows exhibiting
estrus symptoms (standing to be mounted) were confirmed
as described by Roelofs et al. [24] by performing rectal and
transrectal ultrasonographic examinations. Accordingly,
the cow is considered to be in estrus in the presence of a
corpus luteum with a diameter of less than 10 mm or not
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detectable in rectal and ultrasonographic examination, in
the presence of a dominant follicle with a diameter of 12–
25 mm, if the uterus is turgid, its tonocyte is increased and
it is contractile to the touch, if vaginal discharge (cervical
mucus) is clear, slimy and clean.
2.2. Equipment used to evaluate in vivo uterine
contractility
In vivo uterine contractility was evaluated with an
intrauterine pressure (IUP) measuring system with an
open-ended fluid-filled catheter. This system consists
of a data acquisition unit (MP36 Data Acquisition Unit,
Commat Ltd.), a noninvasive external pressure sensor
(SS13L pressure transducer, Commat Ltd.), a software
program (BSL 4.01 Software, Commat Ltd.), a notebook
PC, a thin open-ended polyethylene catheter, transfer
hoses, and a 3-way valve. The system was prepared
following the procedure described by Bajcsy et al. [25] and
calibrated by using the software before each measurement.
The electrical signals (mV) were transformed into pressure
units (mmHg) by the data acquisition unit. The data
acquisition sampling frequency was set to 4 Hz.
2.3. Experimental protocol
The experimental protocol applied in the study is
schematized in Figure 1. Blood samples were collected
from cows defined at estrus to subsequently confirm of
cycle phase with measurement of serum progesterone (P4)
levels and centrifugated at 3500 g for 10 min. to extract
their serum. The sera were kept at –20 °C until measuring
their P4 level.
The tail of the cow at estrus was tied to one side to
prevent erroneous measurements due to tail-wagging
motion. After cleaning the perineal region using an
antiseptic solution, the previously calibrated catheter
was transcervically placed into the uterus. The external
pressure sensor was fixed to the root of the tail with an
adhesive material to prevent reactions of the cow such as
moving foot, urination, and defecation. The catheter was
washed by using a saline solution of 10 mL for preventing
possible catheter blockages. After the adaptation period
(30 min on average), spontaneous IUP changes were
recorded continuously for 30 min. The reactions of the
animal such as coughing, itching, urination, defecation,
hunching, and other significant actions were recorded.
These artefacts were carefully examined and eliminated
during the evaluation and analysis.
Following the spontaneous IUP recording, cows
(n = 28) divided into 4 equal treatment groups consist
of two clinical doses of buserelin treatment (Bus1 and
Bus2), an oxytocin treatment (Oxt) (in order to monitor
the uterotonic effect to check the operability of the IUP
system) and a control group (Con). In Bus1 group (n =
7), 10.5 µg buserelin (0.0042 mg/mL buserelin acetate, 2.5
mL Receptal, MSD Animal Health), in Bus2 group 21 µg
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Figure 1. Schematic diagram of experimental protocol.

buserelin (n = 7) (5 mL, using the same preparation), in
Oxt group (n = 7) 50 IU oxytocin (10 IU/mL oxytocin,
Provet Oksitosin, Provet), and in Con group (n = 7), 5 mL
saline solution were intravenously injected to cows. After
administration of these agents to cows, IUP changes were
recorded for 60 min.
Serum P4 levels were measured using a commercial
ELISA kit (Progesterone ELISA Kit, Cayman Chemical
Company, Catalog No: 582601) following the procedure
recommended by the manufacturing company.
2.4. Data management
For ensuring accuracy and more reliable statistical analysis
of the mathematical data obtained from the IUP recording
graphs, the experimental protocol period was divided
into 9 time periods (TP), each of which lasted 10 min and
named TP1-TP9 as described by Hirsbrunner et al. [11,12].
The periods of the first 30-min spontaneous contractions
were named TP1, TP2, and TP3, respectively and the
contraction periods following the administration of the
agents (60 min) were named TP4-TP9, respectively. An
increase in the IUP graph was considered a pressure wave
in case the peak exceeded the threshold pressure by at least
7 mmHg for 20 s as described in the literatures [4,12].
The software program (BSL 4.0.1 version, Commat
Ltd.) was used to analyse the frequency (FREQ, number
of contractions/10 min), amplitude (AMP, mmHg, the
pressure difference between IUP peak and resting period),

and area under curve (AUC, mmHg × s., the total area
under the curve in 10 min.) of the contractions.
2.5. Statistical analysis
In this study, the sample size was determined by statistical
power analysis with using G*Power 3.1.9.4 version
software program. The required minimum sample size
was determined as 28, taking the effect size (f) 0.23, type
I error (α) 0.05 and power (1-β error) 0.80 (using Cohen
guidelines).
The data obtained by processing the IUP records were
analyzed using SPSS 22.0 software package (Statistical
Package for the Social Sciences for Windows, SPSS 22.0
Edition for Windows, Chicago, IL, USA). In this study,
two-way ANOVA with replication test were used, which
allows to test both factors treatment (TR) and time period
(TP) and their interaction (TR × TP) on independent
variables (FREQ, AMP and AUC). Tukey’s multiplecomparison posttest were also used to find real-time
differences within treatment groups. A difference was
considered to be statistically significant when p < 0.05. The
example of raw graphical tracing was reproduced by using
the BSL 4.0.1 and the graphs were built in by GraphPad
Prism 8.0.2 version.
3. Results
Serum progesterone levels of all cows subjected to this
study were measured to be <1 ng/mL and the mean serum
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progesterone level was determined to be 0.62 ± 0.2 ng/mL.
Therefore, all cows used in the study were confirmed to be
at estrus. Some artefacts were observed due to overactivity
of two cows. However, IUP changes of all cows were
recorded successfully. As IUP changes were rapid and
instantaneous in artefacts, uterine contractions could easily
be distinguished from these erroneous measurements.
3.1. IUP changes of spontaneous uterine contractility at
estrus
The data of the first three periods (TP1-TP3) of all cows (n
= 28) were used to calculate IUP parameters of spontaneous
uterine contractile activity at estrus. The mean ± SEM of
FREQ, AMP and AUC of TP1 to TP3 periods were found
to be 5.11 ± 0.10 contraction cycle, 30.23 ± 0.94 mmHg and
773.43 ± 30.45 mmHg × s., respectively. The contraction
cycles were observed to be nearly uniform and regular.
3.2. IUP changes after drug administration
The two-way ANOVA (treatment × time period) on each
of uterine contractility parameters (FREQ, AMP and
AUC) are presented in Table 1. In visual examination of
the raw graphical tracings, there was only a striking IUP
increase after the injection of 50 IU oxytocin (Figures 2
and 3). In other treatment groups (Con, Bus1 and Bus2),
no significant activity was seen throughout the 90 min
recording period. Similar findings were encountered in
the mathematical analysis of graphical data. Graphical
data of recording period obtained from the software
program is presented in Figure 3. The differences in
frequency between mean spontaneous (TP1-TP3) and
drug-induced (TP4-TP9) contraction periods were
not found to be statistically significant (p > 0.05) for all
groups. While the differences in amplitude of contraction
were not found to be statistically significant for Con, and
Bus2 groups, they were found to be statistically significant
for Bus1 and Oxt group, in which the mean amplitude of
contraction increased by 51.12% following the intravenous
administration of 50 IU oxytocin. This effect of oxytocin
lasted for 13 min on average in the periods TP4 and TP5.
In the Bus1 group, it was determined that the statistical
difference between the time periods in terms of amplitude
and AUC was caused by the TP1 period, and there was no
effect in the TP4-TP9 period as a result of 10.5 µg buserelin
injection. Similarly, the differences in AUC values were
not found to be statistically significant for Con, and Bus2
groups. However, an increase of 51.30% in the AUC of the
trace was observed in the Oxt group.
4. Discussion
It is well-known that in the presence of a preovulatory
follicle, synthetic GnRH agonists induce ovulation by
providing LH surge [26]. In addition to this well-known
conventional effect, recent studies [19–22] have reported
that GnRH had also local regulatory and different
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physiological functions in the reproductive system. As is
known, buserelin is a widely used synthetic GnRH agonist
for ovulation induction after artificial insemination
at estrus. And in this process, uterine contractility
contributes to rapid sperm transfer. Previous studies [2–4,
11–14, 27] investigating the in vivo bovine uterine activity
have focused on changes in contractile activity throughout
the sexual cycle and in postpartum period and effects of
some hormones on uterine contractile activity. In this
study, the main goal is to understand the effect of GnRH
(synthetic agonist) on uterine activity which plays a role in
rapid sperm transport after artificial insemination during
estrus, rather than merely determining the effect of uterine
activity. Therefore, we investigated the effects of two
clinical doses of buserelin on bovine uterine contractility
at estrus from a different perspective.
The data regarding spontaneous IUP changes of cows
at estrus were collected to compare contraction patterns
after buserelin administration. The analysis revealed that
the data were similar to those of previous in vivo studies
[3, 4, 14, 27], in which spontaneous uterine contractions
were analyzed using different techniques.
In the study, the effect of buserelin treatment on
uterine contractility have been observed for 60 min. In the
determination of this period, the time of the spermatozoa
to reach the fertilization site and the pharmacokinetic
properties of buserelin were taken into consideration.
Buserelin was reported to be 25 times more potent
compared to gonadorelin [28], to have higher receptor
affinity [29], and to stimulate LH surge approximately
120 min after intramuscular injection [30]. Its elimination
of half-life is approximately 80 min. Considering the
said pharmacokinetic effects of buserelin, we think that
a period of 60 min would be sufficient to observe the
effects of supraphysiological doses of GnRH on uterine
contractile activity.
We hypothesized that buserelin has a dose dependent
effect on in vivo bovine uterine contractility when
administered at estrus. In order to test this hypothesis,
the effects of treatment (two clinical buserelin dose,
oxytocin and placebo) and time period (TP1 to TP9) and
their interaction on FREQ, AMP and AUC, a two-way
ANOVA (Treatment: 4 × Time period: 9) analysis was
conducted. There were no significant effect of treatment
and time period on FREQ (Table 1). Regarding to AMP,
a significance was determined in Time period. After
the recording of spontaneous uterine contractions,
administration of 50 IU oxytocin, to test the eligibility of
the IUP measuring system, increased up AMP in TP4 and
in TP5 (Figure 2). However, the difference in TP1 in the
BUS2 group (21 µg buserelin) is thought to be insignificant
and possibly due to adaptation process or a system-related
condition. There is no significant difference in AMP after
buserelin administration.
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Table 1. Two-way ANOVA (Treatment (TR) × Time period (TP)) on FREQ, AMP and AUC of
uterine contractility.
Source of variation

SS

df

MS

F

p

Time period (TP)

5.798

8

0.7248

1.112

p = 0.850

Treatment (TR)

9.580

3

0.3193

4.901

p = 0.355

Interaction (TR × TP)

10.92

24

0.4549

0.6982

p = 0.002

Residual (error)
Total

140.7
167.0

216
251

0.6516

Time period (TP)

2466

8

821.9

9.593

p < 0.0001

Treatment (TR)

385.8

3

48.22

0.5628

p = 0.807

Interaction (TR × TP)

1434

24

59.74

0.6973

p = 0.851

Residual (error)
Total

18505
22790

216
251

85.67

Time period (TP)

298865

8

37358

3.804

p = 0.0003

Treatment (TR)

2531521

3

843840

85.92

p < 0.0001

Interaction (TR × TP)

933498

24

38896

3.960

p < 0.0001

Residual (error)
Total

2121478
18592215

216
251

9822

FREQ

AMP

AUC

Intr auter ine pr essur e (mmHg)

FREQ: frequency of contractions, AMP: amplitude of contractions, AUC: area under curve of
contractions, TP: time period, TR: treatment (BUS1, BUS2, OXT, and CON)
SS: sum of squares, df: degrees of freedom, MS: mean square, F: Fisher value.
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Figure 2. Raw graphical tracings of spontaneous and oxytocin-induced
intrauterine pressure (IUP) changes (system control). Arrow represents the
injection of 50 IU oxytocin. After oxytocin injection, there is a noticeable
increase in IUP.

In the literature, there are a few studies on the effects
of GnRH and synthetic agonists on uterine contractility,
however their results are contradictory because of the
difference about species-specific effects. GnRH was
reported to inhibit contractility in isolated rat myometrial

strips [17], however, Giammarino et al. [15] and Manera et
al. [16] reported that increased doses of GnRH stimulated
contractile activity. The researchers also stated that the
inductive effect was more in uterine strips during the
follicular phase and this effect was probably provided
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8
number of contractions / 10 min

Con

Frequency

Bus1
Oxt

Bus2

6
4
2

TP
1
TP
2
TP
3
TP
4
TP
5
TP
6
TP
7
TP
8
TP
9

TP
1
TP
2
TP
3
TP
4
TP
5
TP
6
TP
7
TP
8
TP
9

TP
1
TP
2
TP
3
TP
4
TP
5
TP
6
TP
7
TP
8
TP
9

TP
1
TP
2
TP
3
TP
4
TP
5
TP
6
TP
7
TP
8
TP
9

0

Groups
Amplitude
Con

Intrauterine pressure (mmHg)

60

**

Bus1
Oxt
*

40

Bus2

*
20

TP
1
TP
2
TP
3
TP
4
TP
5
TP
6
TP
7
TP
8
TP
9

TP
1
TP
2
TP
3
TP
4
TP
5
TP
6
TP
7
TP
8
TP
9

TP
1
TP
2
TP
3
TP
4
TP
5
TP
6
TP
7
TP
8
TP
9

TP
1
TP
2
TP
3
TP
4
TP
5
TP
6
TP
7
TP
8
TP
9

0

Groups

1500
Area under curve (mmHg x s)

Con

Area under curve

Bus1
Oxt
*

1000

Bus2

*

500

TP
1
TP
2
TP
3
TP
4
TP
5
TP
6
TP
7
TP
8
TP
9

TP
1
TP
2
TP
3
TP
4
TP
5
TP
6
TP
7
TP
8
TP
9

TP
1
TP
2
TP
3
TP
4
TP
5
TP
6
TP
7
TP
8
TP
9

TP
1
TP
2
TP
3
TP
4
TP
5
TP
6
TP
7
TP
8
TP
9

0

Groups

Figure 3. Mean contractility parameters, 95% confidence interval, of spontaneous and drug-induced IUP recordings through TP1 to
TP9 in treatment groups. There is no significance in terms of frequency of contractions among time periods in groups (a). Statistical
significance was detected in amplitude (b) and area under curve (c) in Bus1 and Oxt groups. Note the difference at TP4 period (just
after the oxytocin injection) in amplitude and AUC of Oxt group. Statistical analyses were calculated by Tukey posthoc test following
significant two-way ANOVA.* < 0.05, ** < 0.01.
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by biologically active GnRH receptors. Additionally, the
same studies highlighted that when GnRH receptors were
invaded by GnRH antagonists, the increased doses of
GnRH did not have an impact on uterine contractility in
strips both follicular and luteal phase.
This in vivo study revealed that two different clinical
doses of buserelin (10.5 µg, 21 µg) did not affect the
uterine activity. Although increased doses of GnRH were
proved to stimulate the contractile activity in isolated
bovine myometrial strips in vitro [15,16], the buserelin
as a GnRH agonist could be stated to have no impact on
stimulating the uterine activity by contributing to rapid
sperm transport for 60 min in oestrous cows in vivo.
The studies investigating the drug and dose-response
effects on uterine activity suggest that the contraction
parameters exhibit a harmonic attitude after drug
administration considering the time of action and
elimination of half-life (30). In our findings, TP1-TP3
periods during which spontaneous uterine activity was
monitored, and TP4-TP9 periods during which the groups
were monitored after administration of appropriate agents
were observed to be uniform in terms of all contractility
parameters in Con and Bus2 groups. In Oxt group, which
was designed to test the eligibility of the IUP measuring

system, a harmonious increase was observed in the
amplitude and AUC of the contraction cycle after the
injection of 50 IU oxytocin. The inconsistency observed
in the Bus1 group in the TP1 period resulted in statistical
differences between periods (Figures 2b and 2c). The
reason for this difference might be due to incomplete
adaptation process after placing the catheter for IUP
measuring, however, no effect has been observed after the
administration of 10.5 µg.
According to results of this study, it was concluded
that buserelin administered in clinical doses (10.5, 21
µg) to cows in estrus did not show any direct effect on in
vivo uterine contractile activity contributing to the rapid
sperm transport, however, more detailed studies should be
carried out to provide sufficient findings on this process.
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